“To broaden our strategy even further we have collaborated with the clinical teams led by Dr Paul Porter at Joondalup Health Campus and Princess Margaret Hospital in Perth to reconfigure our Australian paediatric study to be a double-blind, prospective study that can directly support European (CE) and Australian (TGA) regulatory filings. Within this context we are also excited to be working with the health researchers at Curtin University to provide independent statistical analysis of that study.”
Given the double blind status and work involved in measuring results, plus the statistical work at Curtin, they will probably need a few days to do the work.
Thus my guesswork is for a TH on a Friday morning and results then announced on Tuesday. So Probably a TH next Friday or the one after.
Fox
RAP Price at posting:
13.0¢ Sentiment: Buy Disclosure: Held
